Actions

Newsfeed Popular Local Discover Follows Blocks Bookmarks Filters Settings PowerUps Help Updates

stocktitan.net / Share Newsitem

View, share or embed this newsitem using the details below.

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

Discover SciSparc's FDA application for a groundbreaking Tourette Syndrome treatment. Learn about the phase IIb trial of SCI-110, set to take place at world-renowned medical centers, evaluating efficacy and safety in adult patients.

https://newsreadery.com/go/42261ec869e493ad1e2fe09e262ee92b

Save

Back

Read Full Article